S Jacob

Summary

Country: Germany

Publications

  1. doi request reprint Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss
    S Jacob
    Cardio metabolic Institute, Villingen Schwenningen, Germany
    Diabetes Obes Metab 11:361-71. 2009

Collaborators

Detail Information

Publications1

  1. doi request reprint Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss
    S Jacob
    Cardio metabolic Institute, Villingen Schwenningen, Germany
    Diabetes Obes Metab 11:361-71. 2009
    ..Published data suggest that orlistat 120 mg, a lipase inhibitor used to treat obesity, may improve glycaemic parameters through weight loss-independent effects...